Rare occurrence of occult hepatitis C virus in apparently uninfected injecting drug users: A two-centre, masked, case-control study

Journal of Viral Hepatitis

Volumn 20, Issue 10, 2013, Pages 725-728

  Sugden, P B ^a   Pham, T N Q ^b   Ratnarajah, S ^a   Cameron, B ^a   Bull, R ^a   White, P A ^a   Michalak, T I ^b   Lloyd, A R ^a  

^a UNIVERSITY OF NEW SOUTH WALES   (Australia)

^b MEMORIAL UNIVERSITY OF NEWFOUNDLAND   (Canada)

Author keywords

hepatitis C virus; occult infection; polymerase chain reaction

Indexed keywords

VIRUS RNA;

ARTICLE; CASE CONTROL STUDY; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; FOLLOW UP; GENOTYPE; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; HUMAN TISSUE; INTRAVENOUS DRUG ABUSE; LIMIT OF DETECTION; LONGITUDINAL STUDY; MULTICENTER STUDY; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL;

HEPATITIS C VIRUS; OCCULT INFECTION; POLYMERASE CHAIN REACTION;

ADULT; ASYMPTOMATIC DISEASES; CASE-CONTROL STUDIES; FEMALE; HEPACIVIRUS; HEPATITIS C; HUMANS; LEUKOCYTES, MONONUCLEAR; LONGITUDINAL STUDIES; MALE; PLASMA; PREVALENCE; RNA, VIRAL; SUBSTANCE ABUSE, INTRAVENOUS; YOUNG ADULT;

EID: 84884129531     PISSN: 13520504     EISSN: 13652893     Source Type: Journal    
DOI: 10.1111/jvh.12098     Document Type: Article

References (8)

1. Sugden PB, Cameron B, Bull R, White PA, Lloyd AR,. Occult infection with hepatitis C virus: friend or foe? Immunol Cell Biol 2012; 90 (8): 763-773
2. Teutsch S, Luciani F, Scheuer N, et al,. Incidence of primary hepatitis C infection and risk factors for transmission in an Australian prisoner cohort. BMC Public Health 2010; 10: 633. Epub 2010/10/23.
3. Pham TNQ, MacParland SA, Mulrooney PM, Cooksley H, Naoumov NV, Michalak TI,. Hepatitis C virus persistence after spontaneous or treatment-induced resolution of hepatitis C. J Virol 2004; 78 (11): 5867-5874.
4. Pham ST, Bull RA, Bennett JM, et al,. Frequent multiple hepatitis C virus infections among injection drug users in a prison setting. Hepatology 2010; 52 (5): 1564-1572. Epub 2010/11/03.
5. White PA, Zhai X, Carter I, Zhao Y, Rawlinson WD,. Simplified hepatitis C virus genotyping by heteroduplex mobility analysis. J Clin Microbiol 2000; 38 (2): 477-482. Epub 2000/02/03.
6. White PA, Pan Y, Freeman AJ, et al,. Quantification of hepatitis C virus in human liver and serum samples by using LightCycler reverse transcriptase PCR. J Clin Microbiol 2002; 40 (11): 4346-4348. Epub 2002/11/01.
7. Post JJ, Pan Y, Freeman AJ, et al,. Clearance of hepatitis C viremia associated with cellular immunity in the absence of seroconversion in the hepatitis C incidence and transmission in prisons study cohort. J Infect Dis 2004; 189 (10): 1846-1855.
8. MacParland SA, Pham TNQ, Guy CS, Michalak TI,. Hepatitis C virus persisting after clinically apparent sustained virological response to antiviral therapy retains infectivity in vitro. Hepatology 2009; 49 (5): 1431-1441.